Document Detail


Cervical intraepithelial neoplasia. Examination, treatment and follow-up.
MedLine Citation:
PMID:  3900833     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In inflammatory cytology without suspicion of cervical neoplasia (Papanicolaou II) a pelvic examination is done in order to exclude a macroscopic visible tumor. After treatment of an inflammation a repeat cytology and a colposcopy is performed preferably 8 to 12 weeks later. If the cytology or the colposcopy is abnormal, or if the colposcopy is inconclusive, or if the inflammation is of viral origin, the patient is referred to colposcopy-directed biopsies and endocervical curettage like the patients with an initial cytology suspicious of cervical neoplasia (Papanicolaou III to V). A histologically verified CIN I is treated as soon as it proves itself stable, that is, if biopsies or ECC 3 to 6 months after the initial ones again show CIN I. In very young women treatment may be postponed another 3 to 6 months. Histologically verified CIN II and III are treated without postponement. In CIN I and II treatment by means of destruction is recommended if the neoplasia is located on the exocervix and the preoperative ECC is normal and if colposcopy can exclude (micro-)invasion. A CIN III fulfilling the same criteria may be destructed, too, preferably by the CO2 laser--partly because of the well defined and precise destruction especially with regard to the depth into the stroma and partly because the laser contrary to the cryoapparatus is very suitable of treating CIN involving large areas of the exocervix including neoplasias extending into the vagina. In this connection the combined excision and destruction by the laser should be mentioned, a treatment modality made accessible by the appearance of the laser.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
A Berget; C Lenstrup
Related Documents :
17948873 - Cis-acting factors promoting the cag intergenerational instability in machado-joseph di...
11097353 - Rapid analysis of cgg repeat length in the fmr1 gene.
15341163 - Estimating the strength of sexual selection from y-chromosome and mitochondrial dna div...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Obstetrical & gynecological survey     Volume:  40     ISSN:  0029-7828     ISO Abbreviation:  Obstet Gynecol Surv     Publication Date:  1985 Sep 
Date Detail:
Created Date:  1985-11-12     Completed Date:  1985-11-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0401007     Medline TA:  Obstet Gynecol Surv     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  545-52     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carcinoma in Situ / diagnosis*,  surgery
Cryosurgery
Electrocoagulation
Female
Follow-Up Studies
Humans
Hysterectomy
Laser Therapy
Uterine Cervical Dysplasia / diagnosis*,  surgery
Uterine Cervical Neoplasms / diagnosis*,  surgery
Vaginal Smears

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The use of single photon emission computed tomography in lung imaging with aerosols.
Next Document:  Fetal liver ultrasound measurements during normal pregnancy.